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Clinical high risk for psychosis: the
association between momentary stress,
affective and psychotic symptoms
van der Steen Y, Gimpel-Drees J, Lataster T, Viechtbauer W, Simons
CJP, Lardinois M, Michel TM, Janssen B, Bechdolf A, Wagner M,
Myin-Germeys I. Clinical high risk for psychosis: the association
between momentary stress, affective and psychotic symptoms.
Objective: The aim of this study was to assess associations between
momentary stress and both affective and psychotic symptoms in
everyday life of individuals at clinical high risk (CHR), compared to
chronic psychotic patients and healthy controls, in search for evidence
of early stress sensitization. It also assessed whether psychotic
experiences were experienced as stressful.
Method: The experience sampling method was used to measure affective
and psychotic reactivity to everyday stressful activities, events and
social situations in 22 CHR patients, 24 patients with a psychotic
disorder and 26 healthy controls.
Results: Multilevel models showed significantly larger associations
between negative affect (NA) and activity-related stress for CHR
patients than for psychotic patients (P = 0.008) and for CHR compared
to controls (P < 0.001). Similarly, the association between activity-
related stress and psychotic symptoms was larger in CHR than in
patients (P = 0.02). Finally, the association between NA and symptoms
(P < 0.001) was larger in CHR than in patients.
Conclusion: Stress sensitization seems to play a role particularly in the
early phase of psychosis development as results suggest that CHR
patients are more sensitive to daily life stressors than psychotic patients.
In this early phase, psychotic experiences also contributed to the
experience of stress.
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Significant outcomes
• Momentary emotional and psychotic stress reactivity for unpleasant activities was increased in CHR
patients compared to psychotic patients with longer duration of illness.
• Momentary psychotic symptoms are associated with higher levels of negative affect (NA) in the CHR
patients than in psychotic patients and may therefore be a stressor in itself.
• Stress sensitization seems to play an important role in psychotic disorder, particularly in the early
phase of the illness.
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Limitations
• The experience sampling method (ESM) measures of negative affect, psychosis and daily life stress
are based on subjective reports.
• The cross-sectional nature of the data precludes definitive conclusions about causation.
• The possible influence of medication use on the examined associations could not be tested as CHR
medication use was not yet available.
Introduction
It has long been suggested that stress plays an
important role in the emergence and course of psy-
chotic disorder (1–5). Stressful life events (6), child-
hood adversity (7), as well as small everyday
hassles (8, 9) have been associated with the devel-
opment and course of psychotic disorder. To fur-
ther elucidate the role of stress in the aetiology of
psychotic disorder, attention has shifted to studies
of the putative prodromal phase of a psychotic dis-
order. Participants in such studies are those who
experience subclinical psychotic symptoms and
meet well established prodromal criteria that
describe them to be at ‘ultra high risk’ (UHR) (10)
or ‘clinical high risk’ (CHR) (11) for a transition
to disorder. In this study, the term ‘clinical high
risk’ is utilized.
CHR patients may be more exposed to stressful
experiences. Findings regarding the number of life
events in CHR patients compared to controls are
mixed, with some studies reporting an association
between the occurrence of traumatic experiences as
well as other negative life events and the expression
of subclinical psychotic symptomatology (12–19),
while other studies reported no difference in the
number of major life events (20, 21) or even signifi-
cantly fewer life events (22). Alternatively, CHR
patients may specifically differ in their tolerance of
stress. Indeed, life events (19, 22), as well as daily
life hassles (19), were appraised as significantly
more upsetting by CHR patients than controls.
Additionally, CHR patients reported impaired tol-
erance and increased functional impairment in
response to normal stress compared to healthy
controls (20) and higher self-reported psychosocial
stress levels compared to first-episode psychosis
patients (23).
Previous studies with the Experience Sampling
Method (ESM, a structured diary technique in
which subjects are asked in normal daily life to
report their thoughts, feelings and symptoms, and
also the context (e.g. location, company, activity)
and the appraisal of the context, several times per
day) have shown a higher emotional and psychotic
reactivity to small daily life stressors in psychotic
patients, their unaffected relatives and in those at
psychometric risk for psychotic disorder when
compared to healthy controls (2, 24–27). It has
been suggested that the (repeated) exposure to
early severe stressors increases sensitivity to small
stresses in daily life (2, 4, 28) and that this process
of ‘behavioural sensitization’ is a vulnerability
marker for psychosis.
However, until now, only one ESM study (29)
has investigated both emotional and symptomatic
reactivity to daily life stress in a sample of CHR
participants. Compared to psychotic patients and
controls, the CHR group experienced greater nega-
tive affect (NA) when confronted with stressful
activities and social situations, but not after
unpleasant events (i.e. emotional stress reactivity).
Both the CHR and psychotic patient group
showed an increase in psychotic symptoms in
response to daily life stressors (i.e. psychotic stress
reactivity), in comparison with controls. However,
psychotic stress reactivity was comparable across
patient groups. Their results suggest that stress
reactivity for small daily life stressors and therefore
early stress sensitization, occurs before the onset of
psychotic disorders and is not just the consequence
of a chronic illness.
What is often neglected in stress research is that
psychotic experiences in themselves may be an
important source of distress. A recent study (30)
has shown that intensity of distress related to sub-
clinical symptoms was related to transition risk.
Furthermore, ESM studies with psychotic patients
have reported that psychotic symptoms are associ-
ated with distress and an increase in NA (31–33).
This may be particularly true for CHR patients,
for whom these experiences are new.
Aims of the study
Our aim was to examine (i) whether emotional
reactivity to stress differs in clinical high risk
patients, chronic psychotic patients and healthy
controls, (ii) whether psychotic reactivity to stress
differs in clinical high risk patients vs. chronic psy-
chotic patients and (iii) whether psychotic symp-
toms in itself are increasing negative affect in both
patient groups.
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Methods
Sample
The sample consisted of 27 patients who were diag-
nosed with a non-affective psychotic disorder, 27
participants at CHR for psychosis and 27 healthy
controls. Participants in the CHR group were
between 18 and 45 years of age and had at least
one of the following: (i) attenuated positive symp-
toms; (ii) brief limited intermittent psychotic symp-
toms (BLIPS), both assessed with the Structured
Interview for Prodromal Symptoms (SIPS; 34);
(iii) presence of at least two basic symptoms (e.g.
subtle thought and speech disturbances) assessed
with the Schizophrenia Prediction Instrument,
Adult version (SPI-A; 35); (iv) a significant drop in
functioning (30% or more on the Global Assess-
ment of Functioning (GAF) Scale for at least
1 month within the last year) in combination with
genetic risk; or (v) a significant drop in functioning
plus a diagnosis of schizotypal personality disor-
der. Momentary assessment data for the CHR
group were collected in an add-on study of the
‘PREVENT’ project (for more details see 36), a
large German multisite early recognition and inter-
vention in psychosis project. CHR participants
who took part in PREVENT were randomly
assigned to cognitive behavioural therapy, treat-
ment with Aripiprazole (Abilify©) and medical
management or placebo plus medical management.
As the study is not finished yet, disclosure of the
assignments of our participants is not yet possible.
ESM data collection was started directly after
inclusion in the PREVENT.
Controls between the ages of 18 and 45 years
were recruited by advertisements at the University
of Bonn and other public buildings in Bonn. The
Structured Clinical Interview for DSM-IV axis I
disorders (SCID-I; 37) was used to assess axis I dis-
orders in the CHR group and to exclude any par-
ticipants with a psychiatric disorder from the
control group. Control participants were also
excluded in case of a family history of psychotic
disorder.
The ESM data of the psychotic patients were
gathered as part of an add-on study to the Genetic
Risk and Outcome of Psychosis (GROUP) study
(38), which investigated risk and protective factors
for psychosis. Patients were recruited through in-
and out-patient mental health facilities in the
southern part of the Netherlands and (the Dutch
speaking part of) Belgium. Inclusion criteria for
the patient group were age 16–60 years and a diag-
nosis of schizophrenia or schizoaffective disorder
as assessed with the CASH (Comprehensive
Assessment of Symptoms and History; 39).
Patients with substance-related psychosis and psy-
chosis with a known organic cause were excluded.
For the current analyses, only those patients with
minimum illness duration of 5 years since their
first psychotic episode were selected. Exclusion cri-
teria for all three groups were a history of brain
disease or head injury with loss of consciousness.
All participants gave written informed consent,
conforming to local ethics committee guidelines.
The experience sampling method
The Experience Sampling Method (ESM) is a
within-day, momentary self-assessment technique
(40, 41). Participants received a digital wristwatch,
and self-assessment forms collected in a booklet
for each day. Ten times a day on six consecutive
days, the watch emitted a signal (beep) at unpre-
dictable moments between 7:30 a.m. and 10:30
p.m. After each beep, participants were asked to
immediately report their thoughts, mood, symp-
toms, current context (e.g. their location, social
company, activities) and subjective appraisals of
the current situation. All self-assessments were
rated on seven-point Likert scales. To ensure relia-
bility of the completed reports, participants also
recorded the time of completion of the report,
which was compared with the time at which the
watch had emitted a signal. All reports completed
more than 15 min after the signal were excluded
from the analyses, as previous work (42) has
shown that reports completed after this interval
are less reliable and consequently less valid. Partic-
ipants with less than 20 valid reports (out of 60)
were excluded from the analysis.
Assessment of mood
Negative affect was assessed at each beep with six
mood-related adjectives (down, guilty, insecure,
lonely, anxious, irritated) rated on seven-point Lik-
ert scales (1 = not at all, 7 = very). However,
detailed factor analyses based on the ESM data
collected in several studies conducted in our
department have shown that the ‘down’ and ‘irri-
tated’ variables have high negative cross-loadings
on the positive affect measure (T. Lataster, per-
sonal communication, 43). Therefore, mean scores
on the items ‘guilty’, ‘insecure’, ‘lonely’ and ‘anx-
ious’ were used as a measure of NA in the analyses.
Assessment of momentary psychotic symptoms
Psychotic symptomatology was assessed at each
beep with seven symptom-related items. Hallucina-
tions were asked directly (‘I hear voices’ and ‘I see
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things that are not really there’), while the presence
of delusions was assessed indirectly by items that
include aspects of mental states that are directly
associated with delusions in schizophrenia (44, 45).
These were ‘I cannot get these thoughts out of my
head’; ‘I feel suspicious’; ‘I feel unreal’ and ‘My
thoughts are influenced by others’. The item ‘I am
afraid I will lose control’ is related to psychosis in
general.
Assessment of momentary stress
Stress was conceptualized as the subjectively
appraised stressfulness of distinctive (social) events
and minor disturbances that continually happen in
the natural flow of daily life. Three different stress
measures were computed. For Activity-related
stress, the question ‘What are you doing?’ served
as a starting point. Subsequently, three questions
(i.e. ‘I would rather do something else’; ‘This is dif-
ficult for me’ and ‘I can do this well’, reverse
coded) were scored on a seven-point Likert scale
(1–7) and were combined into a mean activity-
related stress variable. Event-related stress was
based on the question ‘What was the most impor-
tant event since the last beep?’ Participants subse-
quently scored how pleasant/unpleasant the event
was on a bipolar scale (3 very unpleasant, 0 neu-
tral, +3 very pleasant). Positive events (scores 1, 2
and 3) were recorded to zero, and negative scores
multiplied by 1 (i.e. higher scores now reflect
higher stress/unpleasantness levels) for the event-
related stress variable. For Social stress, partici-
pants were asked to indicate whether they were in
the company of others or alone. If they were in
company of one or more persons, they were asked
to rate the item ‘I would prefer to be alone’ (1–7).
This score was used as the social stress variable.
Analyses
Groups were compared with respect to continu-
ously measured baseline characteristics by means
of ANOVAs. Chi-square tests were used to com-
pare groups with respect to categorical variables.
Group comparisons (ANOVAs) were also per-
formed to test whether the average levels of NA,
momentary psychotic symptoms as well as stress
related to unpleasant activities, events and social
situations differed between the psychotic patients,
CHR patients and controls.
For the further analyses, we used multivariate
multilevel models (46, 47), an extension of stan-
dard hierarchical linear models when analysing
multiple (correlated) outcomes. In particular, a
certain pair of variables (e.g. activity stress and
NA) was repeatedly measured within participants
using ESM, as described earlier. For each partici-
pant, we therefore had up to 60 (measurement
occasions) 9 2 (outcomes) = 120 observations
available. The data therefore conformed to a
three-level structure, with the two outcomes nested
within measurement occasions (‘beeps’), which in
turn were nested within participants. To model the
association between the two outcomes at the par-
ticipant and at the beep level, we used a linear
mixed-effects model with two correlated random
effects at the participant level (corresponding to
two dummy variables indicating whether a particu-
lar row of data corresponded to outcome 1 or out-
come 2) and with correlated residuals at the beep
level. The variance–covariance matrices of the ran-
dom effects at the participant level and the residu-
als at the beep level were allowed to be fully
unstructured. Age and gender and their interac-
tions with the dummy variables were included as
covariates in the model, as previous ESM research
has shown a heightened affective stress response in
female compared to male psychotic patients (48)
and participants in the psychotic patient group
were older than those in the CHR and control
groups. As it can be hypothesized that the associa-
tion between stress and psychotic symptoms is
influenced by low mood (i.e. high NA), we ran the
models testing the association between stressors
and momentary psychotic symptoms both with
and without NA and its interactions with the
dummy variables as covariates.
Models were fitted separately in each of the three
groups. To test whether the degree of association
(i.e. correlation) between two outcomes differed
between the groups at the beep level, we extracted
the estimated correlations with their corresponding
standard errors and then conducted Wald-type tests
(i.e. z¼ðq̂1q̂2Þ=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE½q̂12þSE½q̂22
q
; where q̂1 and
q̂2 are the beep-level correlations for the first and
second group, respectively, and SE[q̂1] and SE[q̂2]
denote the corresponding standard errors). The
models were fitted with restricted maximum likeli-
hood (REML) estimation using the mixed routine
in Stata 13.1 (49).
We used this method to investigate whether (i)
the association strength between stress (activity-
related, event-related and social) and NA differed
between the CHR and psychotic patient groups as
well as the CHR and healthy control groups; (ii)
the association strength between stress and
momentary psychotic symptoms differed between
the CHR and psychotic patients groups, once in
the standard model and once in the model with
NA added as a covariate; and (iii) the association
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strength between momentary psychotic symptoms
and negative emotions (symptoms as stressor) dif-
fered between CHR and psychotic patients.
Results
Participants and descriptive statistics
The total sample consisted of 27 healthy controls,
27 CHR patients and 27 psychotic patients. Inclu-
sion criteria were incomplete for three CHR partic-
ipants and were therefore excluded. After
dropping the invalid beeps (i.e. filled out more than
15 min after the actual beep) and selecting those
participants who had filled out a minimum of 20
valid beeps, 26 healthy controls, 22 CHR and 24
patients remained, with a total number of 2950
observations and a mean number of 41.0
(SD = 9.8) beeps.
Demographic and clinical characteristics are
shown in Table 1. The patients were significantly
older than both the CHR patients and controls (F
(2,69) = 17.01, P < 0.001, Tukey–Kramer:
patients > CHR, controls, P < 0.001). Gender
(v2 = 1.61, P = 0.45) and education level
(v2 = 6.13, P = 0.41) were similarly distributed
over the three groups.
The groups did not differ on the mean number
of valid beeps (see Table 2). The CHR and psy-
chotic patient groups reported significantly more
NA and momentary psychotic symptoms when
compared with the controls (see Table 2 for all
Table 1. Sociodemographic and clinical characteristics
Psychotic patients (n = 24) Clinical high risk patients (n = 22) Control subjects (n = 26)
Demographic variables
Age*,†, mean (SD), range 33.9 (8.8), 20–50 25.2 (5.0), 19–38 24.5 (3.6), 19–33
Gender (m/f) 15/9 17/5 16/10
Civil status, n (%)
Not married 15 (63) 19 (86) 21 (81)
Married/living together 6 (25) 1 (5) 4 (15)
Divorced 3 (12)
Widowhood 1 (4)
Missing 2 (9)
Work situation, n (%)
Household 1 (4)
School/education 1 (4) 14 (64) 17 (65)
Regular work 12 (50) 3 (14) 8 (31)
Structured work 3 (13)
Non-structured activities 5 (21) 4 (18)
Other 1 (4)
Missing 2 (8) 1 (4)
Education level, n (%)
No education 1 (5)
Secondary school 17 (71) 15 (68) 22 (85)
Higher education 7 (29) 5 (23) 4 (15)
Missing 1 (5)
Clinical variables
DSM-IV axis I diagnosis (n)
Schizophrenia 15
Schizoaffective disorder 7
Brief psychotic disorder 1
Delusional disorder 1
Major depression 7
Dysthymia 1
Social phobia 2
OCD 2
PTSD 1
Panic disorder 1
Alcohol misuse 1
No diagnosis 10 26
Psychotic episodes (PE), mean (SD), range 2.7 (1.7), 1–8
Illness duration, mean (SD), range 9.6 (5.2), 5.0–21.5
Age of first PE, mean (SD), range 24.3 (6.7), 12–41
Antipsychotic medication use y/n/? 18/4/2
PANSS-positive symptoms 1.83 (0.77)
*Patients are significantly older than controls (P < 0.001).
†Patients are significantly older than clinical high risk patients (P < 0.001).
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results). The CHR group, but not the patient
group reported significantly more activity-related
and social stress in comparison to controls. Fur-
thermore, social stress was significantly higher in
CHR patients compared to psychotic patients,
while the psychotic patients did not differ from
controls. No other significant differences were
observed.
Is the association between stress and negative affect different in
the three groups?
The results of the multivariate multilevel models
showed the correlation coefficients between NA
and activity-related, event-related and social stress
all to be positive, for the psychotic patient group,
CHR group and control group (range 0.11–0.28,
see Table 3). For NA and activity-related stress,
the association was significantly stronger in the
CHR group compared to both the psychotic
patient group (Z = 2.67, P = 0.008) as well as
the healthy controls (Z = 3.68, P = 0.0002), as dis-
played in Fig. 1. The associations between NA and
event-related stress and NA and social stress were
not significantly different in the three groups.
Is the association between stress and momentary symptoms
different for Clinical High Risk vs. psychotic patients?
The correlation coefficients between momentary
psychotic symptoms and activity-related, event-
related and social stress were positive for both the
CHR patients and psychotic patients (range 0.08–
0.24, see Table 3). For momentary psychotic
symptoms and activity-related stress, the associa-
tion was significantly stronger in the CHR group
compared to the psychotic patient group
(Z = 2.29, P = 0.02). While the association
between symptoms and event-related stress was
stronger in the CHR group as compared to psy-
chotic patients, it did not reach statistical signifi-
cance (Z = 1.66, P = 0.10). No group differences
Table 2. Means (standard deviations) and F-test statistics of the number of valid beeps and ESM variables for psychotic patients, CHR patients and controls
Mean (SD)†
F (df = 2, 69) P Tukey–Kramer‡Psychotic patients (n = 24) Clinical high risk patients (n = 22) Control subjects (n = 26)
Valid beeps 41.5 (10.5), range 20–60 38.5 (9.7), range 21–58 42.7 (9.3), range 23–56 1.14 0.33
Activity-related stress 2.53 (0.87) 2.80 (0.69) 2.28 (0.53) 3.22 0.046 3 < 2*
Event-related stress 0.21 (0.43) 0.27 (0.25) 0.15 (0.11) 1.00 0.37
Social stress 1.66 (0.75) 2.59 (1.27) 1.54 (0.60) 9.42 0.0002 1 < 2** & 3 < 2***
NA 1.95 (0.98) 2.02 (0.84) 1.17 (0.21) 10.11 0.0001 3 < 1**, 2**
MPS 1.67 (0.71) 1.68 (0.61) 1.07 (0.17) 10.38 0.0001 3 < 1**, 2**
NA, negative affect; MPS, momentary psychotic symptoms. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
†For each subject, a mean was calculated over all reports, and the mean per subject was additionally aggregated over the group to obtain the group mean (SD).
‡1. Psychotic patients; 2. CHR; 3. controls.
Table 3. Multivariate multilevel model correlations at beep level between the stress variables, negative affect and momentary psychotic experiences, controlled for age and
gender.
Group comparisons Wald test†
Psychotic patients Clinical high risk patients Control subjects 1 vs. 2 (ref) 2 vs. 3 (ref)
Association CC SE 95% CI CC SE 95% CI CC SE 95% CI Z P Z P
AS & NA 0.16 0.03 0.09–0.22 0.28 0.03 0.21–0.34 0.11 0.03 0.05–0.17 2.67 0.008 3.68 <0.001
ES & NA 0.15 0.03 0.09–0.21 0.16 0.03 0.09–0.23 0.12 0.03 0.06–0.18 0.25 0.80 1.00 0.32
SS & NA 0.20 0.04 0.13–0.27 0.16 0.05 0.07–0.25 0.15 0.04 0.08–0.23 0.74 0.46 0.08 0.93
AS & MPS 0.14 0.03 0.07–0.20 0.24 0.03 0.17–0.30 2.29 0.02
AS & MPS* 0.09 0.03 0.03–0.15 0.11 0.03 0.05–0.18 0.53 0.60
ES & MPS 0.08 0.03 0.01–0.14 0.16 0.04 0.09–0.23 1.66 0.10
ES & MPS* 0.03 0.03 0.03–0.10 0.08 0.04 0.01–0.15 1.04 0.30
SS & MPS 0.15 0.04 0.07–0.23 0.19 0.04 0.10–0.27 0.60 0.55
SS & MPS* 0.09 0.04 0.01–0.17 0.12 0.05 0.03–0.21 0.47 0.64
NA & MPS 0.33 0.03 0.27–0.38 0.53 0.03 0.48–0.58 5.42 <0.001
CC, correlation coefficient; SE, standard error; 95% CI, 95% confidence interval; NA, negative affect; MPS, momentary psychotic symptoms; AS, activity-related stress; ES,
event-related stress; SS, social stress.
*Results of models with NA included as a covariate.
†1. Psychotic patients; 2. CHR; 3. controls.
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were detected for symptoms and social stress. In
the additional analyses where NA was added as a
covariate in the models, the association between
activity-related stress and symptoms was no longer
significantly different between groups (Z = 0.53,
P = 0.60), as were none of the other comparisons.
Are momentary psychotic symptoms more emotionally distressing
for clinical high risk vs. psychotic patients?
Positive associations between momentary psy-
chotic experiences and NA were found for the
CHR and psychotic patient groups (see Table 3).
Group comparison showed the association to be
significantly larger in the CHR group than in the
psychotic patients group (Z = 5.42, P < 0.001),
as displayed in Fig. 1.
Discussion
This study investigated emotional and psychotic
reactivity to daily life stress in those at risk for
a psychotic disorder compared to chronic psy-
chotic patients and healthy controls. As hypoth-
esized, our results showed increased emotional
stress reactivity, particularly related to activities,
to be associated with psychosis, mainly at the
early stages of illness. Contrary to our hypothe-
sis, psychotic reactivity in response to unpleas-
ant activities was increased in CHR compared
to chronic psychotic patients. This suggests that
emotional and psychotic stress sensitization
occurs prior to the development of a full-blown
psychotic state. Furthermore, as hypothesized,
CHR patients experienced the psychotic symp-
toms as more distressing compared to chronic
patients.
Emotional and psychotic stress reactivity
Our results of increased emotional stress reactivity
in CHR compared to chronic patients are replicat-
ing the findings of Palmier-Claus et al. (29). Fur-
thermore, results are in line with studies in CHR
samples using questionnaires showing higher psy-
chosocial stress sensitivity in CHR participants
compared to controls (23), reduced tolerance to
normal stress (20), higher self-reported distress in
response to life events (19, 22) as well as to daily
life stressors (15, 50), especially for those reporting
life events to be more distressing, suggestive of
stress sensitization (19). Psychotic stress reactivity,
however, was stronger in the CHR patients com-
pared to psychotic patients, contrary to our
hypothesis based on the findings of Palmier-Claus
et al. (29). One possible explanation for this differ-
ence may be related to selection of the psychotic
patients. We specifically selected psychotic patients
with an illness duration of at least 5 years, to com-
pare our CHR group with chronic patients. The
patient sample of Palmier-Claus et al. (29) is likely
more mixed with both recent onset and more
chronic patients, as they did not provide specific
inclusion criteria in that regard. This is reflected in
the difference in mean illness duration, with our
sample having a mean illness duration of 9.6
(SD = 5.2) years compared to 6.5 (SD = 8.2) years
reported in their paper. Psychotic stress reactivity
may thus be more characteristic of the early psy-
chotic phase and becoming less prominent when
illness duration progresses.
There are several other possible explanations for
our findings of heightened emotional and psy-
chotic stress reactivity in CHR patients compared
to the chronic psychotic patients. First, the CHR
may experience more severe stressors or these may
occur more often than those experienced by the
patient group, as was indeed confirmed by our
findings of increased activity and social stress in
this group. As high levels of social anxiety have
been reported to characterize help-seeking CHR
patients (51, 52), more exposure to social activities
in our CHR group helps to explain the difference
with the psychotic patients, who have possibly
adjusted their lives in order to avoid stressful (so-
cial) situations. Alternatively, less exposure to
activities, events and social situations might be a
consequence of more negative symptoms (53),
which has been related to lower social functioning,
work performance and social skills. In accordance
with this, a recent study comparing negative symp-
toms in psychotic and CHR patients (54) reported
that psychotic patients differed from CHR patients
by reporting less motivation for engagement with
Fig. 1. Left: Correlation coefficients between negative affect
(NA) and activity-related stress (AS) per group. Right: Corre-
lation coefficients between momentary psychotic symptoms
(MPS) and activity-related stress per group. *P ≤ 0.01,
**P ≤ 0.001.
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family and recreational activities. However, as neg-
ative symptoms are profound not only in psychotic
patients but also in help-seeking CHR patients
(55) and the recent study of Cressman et al. (51)
showed the level of anhedonia to be comparable to
that of psychotic patients, the influence on the
reported group difference in exposure to (social)
activities is probably limited.
Second, a recent study has reported that CHR
patients do not seem to possess the skills to effec-
tively cope with stress in general. Compared to
healthy controls, CHR patients used more mal-
adaptive coping strategies (e.g. blaming one’s self
for the occurrence of the event) and fewer adaptive
(e.g. choosing to reinterpret the event in a positive
fashion) coping strategies, and the use of these
strategies might limit their functioning even further
or exacerbate symptoms (56). Furthermore, use of
adequate coping strategies like stress reduction has
been found to predict an improvement with regard
to psychotic symptoms over time (57).
Third, most of our psychotic patients used
antipsychotic medication. It could therefore be
that antipsychotic medication partly dampens
emotional and psychotic stress reactivity, resulting
in the difference observed between our patient
groups. Some evidence comes from a recent study
(58) in which psychotic patients who use antipsy-
chotic medication subjectively reported dampened
emotional experience. However, as not all our psy-
chotic patients were using antipsychotic medica-
tion and some of the CHR patients have been
using medication, use of antipsychotics is unlikely
to fully explain the difference in stress reactivity
between the groups.
Finally, the results of our sensitivity analyses
investigating the influence of low mood on psy-
chotic reactivity underscore the close relationship
between stress, symptoms and low mood. When
NA was added to the psychotic stress reactivity
models, it was no longer significantly higher in the
CHR group compared to more chronic patients,
suggesting that psychotic stress reactivity is medi-
ated by low mood at the early phases of illness.
Psychotic symptoms and distress
The current study provided evidence that psychotic
symptoms in themselves may be a source of dis-
tress, particularly in CHR patients. These symp-
toms are relatively new for CHR patients, and
belief conviction may not have been fully devel-
oped. The unknown nature of these symptoms
may intensify the levels of distress. Results of a
recent study on stigma related to labels and symp-
toms of CHR also identified subclinical psychotic
symptoms in themselves to be a source of distress
(59). CHR patients experienced more stigma from
symptoms than from the psychosis risk-label, and
specifically the ‘shame’ related to symptoms was
associated with depression.
Another possible explanation might be that
CHR patients may have received no or limited
treatment, either psycho-education or psychologi-
cal treatment, for these symptoms as ESM assess-
ment started just after identification of CHR
status, which may result in less effective coping
strategies. A previous ESM study of psychotic
patients (33) indeed showed that a greater endorse-
ment of a psychological explanation of delusions
and hallucinations was related to less disruption of
functioning, less distress and less NA. On the other
hand, chronic patients may differ from CHR
patients in coping strategies they use to deal with
the symptoms. Lardinois et al. (31) showed that
psychotic patients who used more non-psychotic
coping strategies (i.e. active problem-solving or
avoiding, passive illness behaviour and problem-
avoiding) had more conscious appraisal of distress
associated with symptoms than those who adopted
a more symptomatic coping strategy, for example
following or obeying orders induced by the symp-
toms or locking oneself in.
Theoretical and clinical implications
Overall, our findings further support the hypothe-
sis that increased stress reactivity can be viewed as
an affective pathway to psychosis (2). They also
highlight the important role of distress, repre-
sented in this study as an increase in NA, with the
emergence of psychotic symptoms. The results sug-
gest that CHR patients may get caught in a down-
ward spiral of feeling distressed by their psychotic
symptoms, which may in turn increase the intensity
of psychotic symptoms.
Our findings underscore the need for early inter-
vention in CHR patients to interrupt this vicious
cycle. Decreasing stress reactivity as well as
decreasing the distress associated with the psy-
chotic symptoms is relevant in this respect. The
newest generation of cognitive behavioural thera-
pies (CBTs) puts high emphasis on the context
(hence the name ‘contextual CBT’). Stress reduc-
tion techniques, which incorporate elements of
Mindfulness or Acceptance and Commitment
Therapy, may be an effective treatment strategy
(for a review see 60). Given the observation that
CHR patients coping strategies are often ineffec-
tive and can enhance symptoms (56) and use of
adequate strategies have been found to be predic-
tive of improvement in psychotic symptoms (57),
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interventions that help CHR patients to develop
and apply adequate coping strategies are also likely
to be effective.
Limitations
The results should be viewed in the light of several
methodological issues. First, as with all ESM stud-
ies, measurements are based on subjective reports.
Therefore, it can be argued that the results are not
psychometrically precise. However, although sub-
jective reports are considered less reliable (e.g. do
all participants interpret or answer the questions
identically?), previous research indicates that sub-
jective reports can be valid and are important to
understand the changes in symptoms (61).
Second, the items used to assess momentary
psychosis are relatively broad, as items were used
that participants could self-report about. How-
ever, one could question whether they truly
reflect a psychotic state. For example, ‘I cannot
get these thoughts out of my head’ may equally
reflect anxiety or depression. A principal compo-
nent analysis on the psychosis items resulted in
two factors, one factor representing hallucina-
tions (the two hallucination items) and all the
other items loading equally on a second factor,
which would then reflect delusions. However,
does this second factor truly reflect delusions?
All items scored equally strong on the factor
delusions including ‘I feel suspicious’, or ‘My
thoughts are influenced by others’, suggesting
that the composite score most likely represents
delusions. Furthermore, previous studies from
our group showed that the psychosis score as
used in the current paper had concurrent validity
(as the ESM psychosis scores were significantly
correlated with the score on the positive items
but not the negative items of the PANSS) and
convergent validity using the known-groups tech-
nique (as it distinguished patients from relatives
and controls; 26). This supports that the compos-
ite score of all items does reflect psychosis. How-
ever, the psychosis items could be strengthened
in future research for example using focus groups
with people who have experienced psychosis.
Third, the study was cross-sectional and there-
fore, no direct causality can be inferred from these
results. Furthermore, the possibility of reverse
causality cannot be excluded. There is a possibility
that increased NA or increased levels of psychotic
symptoms influence the subjective appraisal of the
environment or that increased NA causes psy-
chotic symptoms to be experienced as more
intense. However, as was suggested previously, the
overall effect would still be for the individual to
experience psychosis associated with an environ-
mental event (26).
Fourth, the possible influence of medication use
to the examined associations could not be tested in
the current study, as CHR medication use was not
yet available. While at present disclosure of treat-
ment is not yet available, CHR participants did
receive either cognitive behavioural therapy, treat-
ment with Aripiprazole (Abilify©) plus medical
management or a placebo plus medical manage-
ment. The majority of psychotic patients used
antipsychotic medication at the time of testing.
Future studies are needed to examine the effect of
medication use properly by comparing patients
groups with and without antipsychotic medication
use.
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